Last updated: October 13, 2023
Sponsor: Arizona State University
Overall Status: Completed
Phase
N/A
Condition
Inflammation
Treatment
Placebos
Maqui berry/omeg-3 fatty acids
Clinical Study ID
NCT04914312
STUDY00014007
Ages 50-85 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Males and females 50-85 years old
- Generally healthy, non-smoker
- Able to provide informed consent
- BMI: 30-40 kg/m2
Exclusion
Exclusion Criteria:
- Existing auto-immune conditions
- Use of warfarin or other blood thinners
- Use of anti-inflammatory drugs, cardiovascular medications, lipid-altering drugs, andhormone replacement therapy
- Individuals engaged in vigorous exercise (>2 x 30 min/week), vegetarians, and peoplewho routinely take multivitamins or herbal supplements.
Study Design
Total Participants: 32
Treatment Group(s): 2
Primary Treatment: Placebos
Phase:
Study Start date:
January 15, 2022
Estimated Completion Date:
August 15, 2023
Study Description
Connect with a study center
Arizona State University
Phoenix, Arizona 85004
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.